Category: BOCCADASSE 7sept

Successful treatment and durable remission of refractory thrombotic thrombocytopenic purpura (TTP) with belimumab

by Ryan Woods | Jul 31, 2019 | BOCCADASSE 7sept | 0 |

Ryan R Woods MD*12, Andrew M. Farland MD12, Peter J Miller MD1, John Owen MD1, Kathy Batt MD1,...

Read More

In-depth epitope mapping of anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura patients using a large library of ADAMTS13 fragments

by Kadri Kangro | Jul 31, 2019 | BOCCADASSE 7sept | 0 |

Kadri Kangro1, Elien Roose1, An-Sofie Schelpe1, Edwige Tellier2, Gilles Kaplanski2, Jan Voorberg3,...

Read More

APAC, a dual AntiPlatelet and AntiCoagulant, towards a local vascular targeting antithrombotic

by Riitta Lassila | Jul 31, 2019 | BOCCADASSE 7sept | 0 |

R. Lassila1-2, A. Jouppila31Comprehensive Cancer Center, Dept of Hematology, Coagulation Disorders...

Read More

Investigation of the ADAMTS13 c.3178C>T mutation in hereditary and acquired thrombotic thrombocytopenic purpura

by György Sinkovits | Jul 31, 2019 | BOCCADASSE 7sept | 0 |

György Sinkovits1, Edina Szabó1, Dorottya Csuka1, Ágnes Szilágyi1, Johanna A Kremer Hovinga2,...

Read More

Rare bleeding disorders in the pediatric population of Northern Greece: a 10-year single center experience

by Alkistis Adramerina | Jul 31, 2019 | BOCCADASSE 7sept | 0 |

M.Economou1, A.Adramerina1, A.Teli1, S.Symeonidis1, S.Vakalopoulou211st Pediatric Department...

Read More